Suppr超能文献

局部环孢素 A 对干眼症患者临床发现和疾病细胞学分级的影响。

The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye.

机构信息

Department of Ophthalmology, Ankara University School of Medicine, Ankara, Turkey.

出版信息

Cornea. 2010 Dec;29(12):1412-6. doi: 10.1097/ICO.0b013e3181e7845b.

Abstract

PURPOSE

To compare the clinical findings and the cytological grade of the disease before and after 6 months of topical cyclosporine A treatment in patients with dry eye.

SETTING

: This single-center prospective study was performed at the Department of Ophthalmology, Ankara University School of Medicine, between January 2007 and June 2008.

METHOD

Forty-five patients with dry eye (with 5 mm/5 minutes or less Schirmer test) were included in the study. Patients were treated with cyclosporine A 0.005% ophthalmic emulsion (RESTASIS) twice daily in addition to lubricant eyedrops 5 times a day. Schirmer test values, tear breakup time (BUT), and impression cytology (goblet cell density, nucleus to cytoplasmic ratio, and epithelial cell morphology) were evaluated at baseline and after 6 months.

RESULTS

Before and after 6 months of the treatment with topical cyclosporine A, the median Schirmer test scores were found as 3.00 and 4.00 mm, respectively. The median BUT score at baseline was 4.00 seconds, and after treatment, the median score was 5.00 seconds. There were statistically significant differences in the median Schirmer and BUT values between, before, and after 6 months of treatment (P < 0.05). The mean cytological grade according to Nelson grading system was 1.84 at baseline and 1.51 after treatment with topical cyclosporine A for 6 months. Statistically significant improvement in cytological grades after treatment was observed (P < 0.05).

CONCLUSION

Treatment of patients with dry eye for 6 months with topical cyclosporine A resulted in an increase in Schirmer test results, an increase in BUT scores, and an improvement in cytological grade of the disease.

摘要

目的

比较干眼症患者在使用环孢素 A 局部治疗 6 个月前后的临床发现和细胞学分级。

地点

这项单中心前瞻性研究于 2007 年 1 月至 2008 年 6 月在安卡拉大学医学院眼科进行。

方法

45 例干眼症患者(Schirmer 试验 5 分钟时少于 5mm)纳入研究。患者接受环孢素 A 0.005%眼用乳液(RESTASIS),每日两次,同时使用 5 次/天的润滑滴眼剂。在基线和 6 个月时评估 Schirmer 试验值、泪膜破裂时间(BUT)和印迹细胞学(杯状细胞密度、核质比和上皮细胞形态)。

结果

在使用局部环孢素 A 治疗前和 6 个月后,中位数 Schirmer 试验评分分别为 3.00mm 和 4.00mm。基线时 BUT 评分中位数为 4.00 秒,治疗后中位数为 5.00 秒。治疗前后 Schirmer 和 BUT 中位数评分有统计学差异(P < 0.05)。根据 Nelson 分级系统,治疗前平均细胞学分级为 1.84,治疗 6 个月后为 1.51。治疗后细胞学分级明显改善(P < 0.05)。

结论

干眼症患者局部使用环孢素 A 治疗 6 个月可增加 Schirmer 试验结果、增加 BUT 评分并改善疾病的细胞学分级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验